Breast Cancer-Targets and Therapy

Papers
(The H4-Index of Breast Cancer-Targets and Therapy is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
<p>Resistance and Overcoming Resistance in Breast Cancer</p>45
Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review36
A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer35
Polyethyleneimine (PEI) as a Polymer-Based Co-Delivery System for Breast Cancer Therapy20
Mangifera indica (Mango): A Promising Medicinal Plant for Breast Cancer Therapy and Understanding Its Potential Mechanisms of Action20
Micropapillary Breast Carcinoma: From Molecular Pathogenesis to Prognosis20
Antiproliferation Activity and Apoptotic Mechanism of Soursop (Annona muricata L.) Leaves Extract and Fractions on MCF7 Breast Cancer Cells20
<p>Knowledge, Attitude and Practice Around Breast Cancer and Mammography Screening Among Jordanian Women</p>18
Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives17
Potentiating the Cytotoxic Activity of a Novel Simvastatin-Loaded Cubosome against Breast Cancer Cells: Insights on Dual Cell Death via Ferroptosis and Apoptosis13
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data12
Targeted Treatment for High-Risk Early-Stage Triple-Negative Breast Cancer: Spotlight on Pembrolizumab11
0.031520843505859